Paula’s Choice Multi-Peptide Booster: two studies behind two promises

The US page lists a 0.67 fl oz full size and a 0.17 fl oz travel option. It describes six peptides in a water-light gel serum, rather than a moisturizer cream. Those details identify the product being discussed; neither the size choices nor the gel texture establishes what concentration each peptide contributes. Current Booster identity and description

The FAQ says the newer Booster uses more specialized peptides than the original, while retaining a similar light gel texture. This is the company’s version explanation, not evidence that the older product’s studies apply unchanged. Our OneSkin review offers another peptide product discussion with its own formula and evidence questions. Booster version FAQ

The description identifies six peptides, amino acids and hyaluronic acid, and the FAQ names Tridecapeptide-1 when explaining the rapid-line claim. These details are useful, but the full ingredient declaration was not available in the information supporting this review. We therefore cannot list every component or calculate amounts from the marketing highlights. Booster ingredients and FAQ

A more complete formula would help a reader discuss the exact preparation instead of a peptide count alone. The SkinMedica HA5 review is another record to explore without treating different technology names as equivalent ingredients. For Paula’s Choice, the practical gap remains the current whole formula and the evidence connected to that version. Current Booster description

The firming and smoothing claim is tied to an independent clinical study with 31 subjects after four weeks. That gives the product claim a stated group and duration. The reviewed page does not provide the complete report or comparator, so the result cannot be expanded into a measured advantage over another serum or a guaranteed personal response. Four-week product footnote

FTC’s guidance emphasizes matching research to the exact advertised product, benefit and population. Here, that framework supports keeping this four-week study attached to the Booster’s stated firming and smoothing claim. It does not independently confirm the company’s result or supply the details missing from the trial account. FTC product and population relevance

The separate line-smoothing claim cites 35 people after fifteen minutes in a study of a key ingredient. It is not described as the same 31-person Booster study. The FAQ links the rapid effect to Tridecapeptide-1, but an ingredient explanation does not erase the distinction between testing an ingredient and testing the complete finished serum. Rapid-result footnote and explanation

That difference does not make the ingredient finding meaningless. It changes the question: how does the tested material relate to the exact Booster formula being sold? FTC guidance identifies formulation and tested outcomes as relevant considerations. Without that matching account, the ingredient result should remain an ingredient result, with its own group and measurement point. FTC evidence matching Booster study footnotes

The FAQ tells readers to expect smoother-looking expression lines within fifteen minutes, lasting up to four hours, and further changes after four weeks. That is a more direct consumer promise than the ingredient footnote alone establishes. The two descriptions belong together in a careful review, rather than allowing the unqualified promise to replace its narrower evidence context. Booster result FAQ

A useful question for the brand is which finished-product evidence supports each part of that timeline. Our prescription questions guide concerns a different category of care, but also explains why a named preparation matters. This retail Booster is not a facial estriol prescription, and its cosmetic study cannot answer a hormone-treatment question. Booster product and study description

The FAQ explains that the Booster can have a noticeable scent from an ingredient despite being fragrance-free. It identifies Tridecapeptide-1 as the main source and notes that perceptions differ. This is a helpful product detail for readers who care about smell: a fragrance-free description does not necessarily promise an odorless experience. Booster scent explanation

The same FAQ broadly reassures people with sensitive or rosacea-prone skin. We do not turn that wording into an individual assessment. With the complete declaration unavailable here, the accurate position is to preserve the company’s description and its scent explanation while leaving a particular reaction or compatibility question unanswered. No layering or application plan follows from this review. Manufacturer sensitivity wording

This Booster’s appeal is concrete: a light gel texture, a named peptide blend and a product study with a stated duration. Its limitations are concrete too: incomplete formula information and a rapid-result footnote that concerns one ingredient. Keeping both sides visible allows a useful product discussion without declaring a clinical winner among unlike serums. Booster description and footnotes

FDA’s appearance-versus-drug framework helps keep a cosmetic aim separate from medical treatment; it does not approve this product’s benefits. Our facial versus menopause treatment guide and medication-list guide address other care questions. The Booster review can remain specific: what exactly was tested, in whom, and which promise does that test support? FDA intended-use context